Legend Biotech (NASDAQ:LEGN) Upgraded to Sector Outperform at Scotiabank
Scotiabank upgraded shares of Legend Biotech (NASDAQ:LEGN – Free Report) from a sector perform rating to a sector outperform rating in a research report sent to investors on Wednesday morning, Marketbeat.com reports. The brokerage currently has $65.00 target price on the stock. Other equities analysts have also recently issued research reports about the stock. UBS […]
More Stories
Trump to Ease Tariff Impact on US Carmakers, Lutnick Says
By Aldgra Fredly President Donald Trump will ease some levies imposed on foreign auto parts intended for use in U.S.-made...
Guggenheim Capital LLC Has $246,000 Stock Holdings in Scorpio Tankers Inc. (NYSE:STNG)
Guggenheim Capital LLC trimmed its stake in shares of Scorpio Tankers Inc. (NYSE:STNG – Free Report) by 54.6% during the...
Amazon.com, Inc. (NASDAQ:AMZN) Shares Sold by Aufman Associates Inc
Aufman Associates Inc cut its holdings in Amazon.com, Inc. (NASDAQ:AMZN) by 9.6% during the fourth quarter, HoldingsChannel reports. The fund...
Raymond James Financial Inc. Makes New $2.99 Million Investment in Planet Fitness, Inc. (NYSE:PLNT)
Raymond James Financial Inc. purchased a new stake in shares of Planet Fitness, Inc. (NYSE:PLNT – Free Report) in the...
Tsai Capital Corp Sells 328 Shares of Amazon.com, Inc. (NASDAQ:AMZN)
Tsai Capital Corp trimmed its holdings in shares of Amazon.com, Inc. (NASDAQ:AMZN) by 1.1% during the fourth quarter, according to...
Amazon.com, Inc. (NASDAQ:AMZN) Stake Lowered by Mechanics Financial Corp
Mechanics Financial Corp decreased its stake in Amazon.com, Inc. (NASDAQ:AMZN) by 0.9% during the 4th quarter, according to the company...